Acasti Pharma | ACST - Ebit

Stock Price
3.71
Daily Change
-0.04 -1.07%
Monthly
2.20%
Yearly
16.67%
Q1 Forecast
3.54

Acasti Pharma reported $-3.7M in EBIT for its fiscal quarter ending in December of 2024.





Ebit Change Date
Acasti Pharma USD -3.7M 1.13M Dec/2024
Addus HomeCare USD 32.94M 50K Sep/2025
Amarin USD -1.7M 8.47M Sep/2025
Cassava Sciences USD -11.86M 33.53M Sep/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Option Care Health USD 84.51M 1.2M Sep/2025
Organigram Holdings CAD -28.05M 25.94M Sep/2025
Tilray USD -20.01M 9.34M Sep/2025